BRIEF-Trovagene reports agreement to utilize trovera® ctdna tests and services in cancer clinical trials
* Trovagene announces agreement with global biopharmaceutical company to utilize trovera® ctdna tests and services in cancer clinical trials
May 16 Top choice Medical Investment Co Inc :
* Says it received an administrative order from Zhejiang Regulatory Bureau of China Securities Regulatory, regarding inaccuracy in information disclosure
Source text in Chinese: goo.gl/PbWH1k
Further company coverage: (Beijing Headline News)
FRANKFURT, June 22 Germany and France have agreed to divide regulation of banking and drugs between them after Britain leaves the European Union, the German magazine WirtschaftsWoche reported on Thursday, citing anonymous EU sources.
* Hydropothecary receives expanded cannabis production and sales licence and approval for two new buildings